PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, giving promising improvements throughout different clinical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, far more dependable different for therapeutic use